129 related articles for article (PubMed ID: 9788627)
1. Pluripotent tumor cells in benign pituitary adenomas associated with multiple endocrine neoplasia type 1.
Weil RJ; Huang S; Pack S; Vortmeyer AO; Tsokos M; Lubensky IA; Oldfield EH; Zhuang Z
Cancer Res; 1998 Oct; 58(20):4715-20. PubMed ID: 9788627
[TBL] [Abstract][Full Text] [Related]
2. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
3. Multiple endocrine neoplasia type 1-associated cystic pancreatic endocrine neoplasia and multifocal cholesterol granulomas.
Kimura N; Komuro K; Uchino S; Yagihashi S; Ishidate T; Ishizaka M
Pathol Int; 2010 Apr; 60(4):321-5. PubMed ID: 20403035
[TBL] [Abstract][Full Text] [Related]
4. Clinical and genetic features of familial pituitary adenomas.
Daly AF; Jaffrain-Rea ML; Beckers A
Horm Metab Res; 2005 Jun; 37(6):347-54. PubMed ID: 16001326
[TBL] [Abstract][Full Text] [Related]
5. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.
Crabtree JS; Scacheri PC; Ward JM; Garrett-Beal L; Emmert-Buck MR; Edgemon KA; Lorang D; Libutti SK; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1118-23. PubMed ID: 11158604
[TBL] [Abstract][Full Text] [Related]
6. [Molecular genetic changes in hypophyseal adenomas].
Mennel HD
Strahlenther Onkol; 2001 Jul; 177(7):373-4. PubMed ID: 11505626
[No Abstract] [Full Text] [Related]
7. Perivascular cells harboring multiple endocrine neoplasia type 1 alterations are neoplastic cells in angiofibromas.
Vortmeyer AO; Böni R; Pack SD; Darling TN; Zhuang Z
Cancer Res; 1999 Jan; 59(2):274-8. PubMed ID: 9927030
[TBL] [Abstract][Full Text] [Related]
8. Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1.
Korsisaari N; Ross J; Wu X; Kowanetz M; Pal N; Hall L; Eastham-Anderson J; Forrest WF; Van Bruggen N; Peale FV; Ferrara N
Clin Cancer Res; 2008 Jan; 14(1):249-58. PubMed ID: 18172277
[TBL] [Abstract][Full Text] [Related]
9. [Genetics of familial pituitary adenomas].
Beckers A; Jaffrain-Rea ML; Daly AE
Bull Acad Natl Med; 2009 Oct; 193(7):1557-70; discussion 1570-1. PubMed ID: 20669636
[TBL] [Abstract][Full Text] [Related]
10. A pleiomorphic GH pituitary adenoma from a Carney complex patient displays universal allelic loss at the protein kinase A regulatory subunit 1A (PRKARIA) locus.
Bossis I; Voutetakis A; Matyakhina L; Pack S; Abu-Asab M; Bourdeau I; Griffin KJ; Courcoutsakis N; Stergiopoulos S; Batista D; Tsokos M; Stratakis CA
J Med Genet; 2004 Aug; 41(8):596-600. PubMed ID: 15286154
[TBL] [Abstract][Full Text] [Related]
11. Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors.
Vortmeyer AO; Lubensky IA; Skarulis M; Li G; Moon YW; Park WS; Weil R; Barlow C; Spiegel AM; Marx SJ; Zhuang Z
Mod Pathol; 1999 Sep; 12(9):919-24. PubMed ID: 10496602
[TBL] [Abstract][Full Text] [Related]
12. Pituitary lesions in multiple endocrine neoplasia syndrome (MENS) type 1.
Capella C; Riva C; Leutner M; La Rosa S
Pathol Res Pract; 1995 May; 191(4):345-7. PubMed ID: 7479350
[TBL] [Abstract][Full Text] [Related]
13. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1.
Stratakis CA; Schussheim DH; Freedman SM; Keil MF; Pack SD; Agarwal SK; Skarulis MC; Weil RJ; Lubensky IA; Zhuang Z; Oldfield EH; Marx SJ
J Clin Endocrinol Metab; 2000 Dec; 85(12):4776-80. PubMed ID: 11134142
[TBL] [Abstract][Full Text] [Related]
14. Multiple endocrine neoplasia type 1: from bedside to benchside.
Yoshimoto K
J Med Invest; 2000 Aug; 47(3-4):108-17. PubMed ID: 11019489
[TBL] [Abstract][Full Text] [Related]
15. Tumorigenicity in the nude mouse of cocultures derived from two nontumorigenic cell types, human pituitary adenomas and mouse C3H 10T1/2 fibroblasts.
U HS; Kelley P; Ashbaugh S; Tatsukawa K; Werner R
Cancer Res; 1987 Nov; 47(21):5678-83. PubMed ID: 2822231
[TBL] [Abstract][Full Text] [Related]
16. Pituitary tumors in patients with MEN1 syndrome.
Syro LV; Scheithauer BW; Kovacs K; Toledo RA; Londoño FJ; Ortiz LD; Rotondo F; Horvath E; Uribe H
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):43-8. PubMed ID: 22584705
[TBL] [Abstract][Full Text] [Related]
17. [Familial pituitary tumors].
Yoshimoto K; Saito S
Nihon Rinsho; 1995 Nov; 53(11):2691-6. PubMed ID: 8538028
[TBL] [Abstract][Full Text] [Related]
18. [Thymus carcinoid associated with type 1 multiple endocrine neoplasm syndrome].
Martínez Cerezo FJ; Garreta J; González T; Pardina M; Gallel P; Miralbés M
Med Clin (Barc); 1996 Jan; 106(1):21-3. PubMed ID: 8750538
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of pituitary adenomas.
Donangelo I; Melmed S
J Endocrinol Invest; 2005; 28(11 Suppl International):100-5. PubMed ID: 16625857
[TBL] [Abstract][Full Text] [Related]
20. [Pituitary pathology and MEN 1].
Betea D; Valdes Socin H; Beckers A
Ann Endocrinol (Paris); 2000 Sep; 61(3):214-23. PubMed ID: 10970947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
